EDGAR Filing Documents for 0001193125-22-159821

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-22-159821

Filing Date

2022-05-25

Accepted

2022-05-25 17:18:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d338619ddefa14a.htm	DEFA14A	34890
2	GRAPHIC	g338619g0525053449980.jpg	GRAPHIC	5999
	Complete submission text file	0001193125-22-159821.txt		44307

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121

Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100

Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39376 | Film No.: 22964175
SIC: 2836 Biological Products, (No Diagnostic Substances)